CL2011000120A1 - Proceso de preparacion de compuestos 2-amino-tiazolonas sustituidas. - Google Patents

Proceso de preparacion de compuestos 2-amino-tiazolonas sustituidas.

Info

Publication number
CL2011000120A1
CL2011000120A1 CL2011000120A CL2011000120A CL2011000120A1 CL 2011000120 A1 CL2011000120 A1 CL 2011000120A1 CL 2011000120 A CL2011000120 A CL 2011000120A CL 2011000120 A CL2011000120 A CL 2011000120A CL 2011000120 A1 CL2011000120 A1 CL 2011000120A1
Authority
CL
Chile
Prior art keywords
amino
thiazolones
substituted
compounds
preparation process
Prior art date
Application number
CL2011000120A
Other languages
English (en)
Inventor
Seb Caille
Sheng Cui
Silas Wang
Margaret Faul
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of CL2011000120A1 publication Critical patent/CL2011000120A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Proceso para la preparación de 2-amino-tiazolonas, 2-amino-oxazolonas o 2-amino-diazolonas sustituidas o un tautomero, esteroisomer o sal farmacéuticamente aceptable del mismo.
CL2011000120A 2008-07-29 2011-01-19 Proceso de preparacion de compuestos 2-amino-tiazolonas sustituidas. CL2011000120A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8454908P 2008-07-29 2008-07-29

Publications (1)

Publication Number Publication Date
CL2011000120A1 true CL2011000120A1 (es) 2011-06-24

Family

ID=41020998

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000120A CL2011000120A1 (es) 2008-07-29 2011-01-19 Proceso de preparacion de compuestos 2-amino-tiazolonas sustituidas.

Country Status (20)

Country Link
US (2) US8501954B2 (es)
EP (1) EP2321290B1 (es)
JP (1) JP2011529896A (es)
KR (1) KR20110048520A (es)
CN (1) CN102112454B (es)
AU (1) AU2009276757A1 (es)
BR (1) BRPI0916270A2 (es)
CA (1) CA2730711A1 (es)
CL (1) CL2011000120A1 (es)
CY (1) CY1113135T1 (es)
DK (1) DK2321290T3 (es)
EA (1) EA019573B1 (es)
ES (1) ES2386613T3 (es)
IL (1) IL210562A (es)
MX (1) MX2011001009A (es)
PL (1) PL2321290T3 (es)
PT (1) PT2321290E (es)
SI (1) SI2321290T1 (es)
WO (1) WO2010014586A1 (es)
ZA (1) ZA201100358B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR072538A1 (es) 2008-07-29 2010-09-01 Boehringer Ingelheim Int Derivados de indolinonas, composiciones farmacéuticas y usos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0510394A (pt) * 2004-05-24 2007-11-13 Amgen Inc inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1
JP5204662B2 (ja) * 2005-11-22 2013-06-05 アムジエン・インコーポレーテツド １１−β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤
EP1951695B1 (en) * 2005-11-22 2009-12-23 Amgen Inc. CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1
CA2692128A1 (en) * 2007-06-21 2008-12-31 Amgen Inc. Process for making substituted 2-amino-thiazolones

Also Published As

Publication number Publication date
PL2321290T3 (pl) 2012-11-30
CA2730711A1 (en) 2010-02-04
US20110178307A1 (en) 2011-07-21
EA201170072A1 (ru) 2011-08-30
AU2009276757A1 (en) 2010-02-04
DK2321290T3 (da) 2012-07-16
HK1154000A1 (en) 2012-04-13
WO2010014586A1 (en) 2010-02-04
MX2011001009A (es) 2011-04-27
EP2321290A1 (en) 2011-05-18
US20130345432A1 (en) 2013-12-26
JP2011529896A (ja) 2011-12-15
CY1113135T1 (el) 2016-04-13
IL210562A (en) 2013-11-28
SI2321290T1 (sl) 2012-09-28
CN102112454B (zh) 2013-09-04
EP2321290B1 (en) 2012-06-20
ZA201100358B (en) 2011-10-26
CN102112454A (zh) 2011-06-29
PT2321290E (pt) 2012-08-10
ES2386613T3 (es) 2012-08-23
EA019573B1 (ru) 2014-04-30
KR20110048520A (ko) 2011-05-11
US8501954B2 (en) 2013-08-06
BRPI0916270A2 (pt) 2018-10-16
IL210562A0 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
CO6531458A2 (es) Nuevos compuestos de espiropiperidina
ECSP12011930A (es) Nuevos compuestos de espiropiperidina
CR20110432A (es) Pirimidinas fusionadas
LT4021901T (lt) Pakeistieji piridopirimidinonilo junginiai, naudotini kaip t ląstelių aktyvatoriai
LT3728215T (lt) Raceminio nikotino gavimo etilnikotinato reakcijoje su n-vinilpirolidonu, dalyvaujant natrio etanoliatui arba kalio etanoliatui, arba jų mišiniams, būdas, vykdant sintezę viename inde
EA201170872A1 (ru) Ингибиторы протеинкиназы
NO2018016I2 (no) Niraparib eller et farmasøytisk akseptabelt salt, stereoisomer eller tautomer derav
DOP2006000170A (es) Nuevos derivados de espirocromanona
CY1118478T1 (el) Παραγωγα τυπου αζαϊνδαζολιου ή διαζαϊνδαζολιου για τη θεραπεια του πονου
MX349950B (es) Profarmacos de treprostinil enlazados a un portador.
MX2012003389A (es) Moduladores de gpr40 de pirrolidina.
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
CL2014000202A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-3-metil-butil)-1h(1,2,4)triazol sustituidos; proceso para preparar dicho compuesto; uso de dichos compuestos para combatir hongos fitopatogenos.
UY32153A (es) Inhibidores de piridomidinona de pi13ka(alfa) y mtor
DOP2011000183A (es) Polimorfos de(s)-3-amino-metil-7-(3-hidroxi-propoxi)-3h-benzo-[c][1,2-oxaborol-1-ol
CL2013003686A1 (es) Compuestos derivados de ergolina, antagonista del receptor de 5-ht1d; útiles para el tratamiento de la migraña.
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
FR2916435B1 (fr) Nouveau procede de preparation de la zolithe eu-1.
EA201490761A1 (ru) R(+)-n-формилпропаргиламиноиндан
DOP2019000021A (es) Derivado de triazolopirazinona útil como un inhibidor de pde1 humana
EA201390603A1 (ru) Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин
EA201001828A1 (ru) Способ синтеза производных 3,6-дигидро-1,3,5-триазина
PH12014501327A1 (en) Processes for making magnolol analogs